A Multicenter Phase I Gene Therapy Clinical Trial Involving Intraperitoneal Administration of E1A-Lipid Complex in Patients with Recurrent Epithelial Ovarian Cancer Overexpressing HER-2/<b> <i>neu</i> </b> Oncogene
Srinivasan Madhusudan(Nottingham University Hospitals NHS Trust), Trivadi S. Ganesan(Churchill Hospital), Elizabeth Flanagan(Churchill Hospital), Mark Charnock(John Radcliffe Hospital), Nicholas P Bates(Churchill Hospital), Ayala Tamir(Hammersmith Hospital), Nicholas R. Lemoine(Queen Mary University of London), Nagy Habib(Hammersmith Hospital), Peter Harper(Fondazione IRCCS Istituto Nazionale dei Tumori), Hilary Thomas(University of Surrey), Joanna P. Nicholls(Imperial College London), Robert I. Lechler(King's College London), Desmond P.J. Barton(NIHR Biomedical Research Centre at The Royal Marsden and the ICR), Michael J. Seckl(Charing Cross Hospital), Martin Gore(Imperial College London), Massimo Pignatelli(Nazarbayev University)
Cited by 69
Related Papers
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
|New England Journal of Medicine|2010|4.5k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k